Ticker Symbol: RCOR

Renovacor Inc

$9.00 - 20-12-2024 4 p.m. ET

Exchange: NYSE MKT LLC Currency: USD Asset Type: Common Stock CIK:0001799850

Company Profile

Renovacor is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor’s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Standard Industrial Classification Code (SIC code): 2836

Address: N/A

Website: renovacor.com

CEO: N/A

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: $0.15 ( 4.92%)

Days Range: $3.20 - $3.20

Beta: -

52wk. High: $9.74

52wk. Low: $1.34

Ytd. Change -53.52%

50 Day Moving Average: $2.89

200 Day Moving Average: $2.21

Shares Outstanding: 17269415

Valuation

Market Cap: 5.5B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A